Pathstone Family Office’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$9.67M Buy
22,208
+9,305
+72% +$4.22M 0.07% 176
2023
Q2
$5.62M Sell
12,903
-1,017
-7% -$469K 0.08% 150
2023
Q1
$6.4M Sell
13,920
-20,648
-60% -$9.83M 0.1% 134
2022
Q4
$15.5M Buy
34,568
+7,052
+26% +$3.58M 0.13% 121
2022
Q3
$12.5M Buy
27,516
+17,634
+178% +$8.44M 0.11% 119
2022
Q2
$4.77M Sell
9,882
-283,477
-97% -$140M 0.11% 108
2022
Q1
$5.49M Buy
293,359
+282,508
+2,604% +$129M 0.13% 79
2021
Q4
$5.03M Buy
10,851
+1,447
+15% +$609K 0.13% 80
2021
Q3
$3.51M Buy
9,404
+2,876
+44% +$1.09M 0.1% 102
2021
Q2
$2.49M Buy
6,528
+2,374
+57% +$907K 0.07% 140
2021
Q1
$1.49M Buy
4,154
+4,010
+2,785% +$1.29M 0.05% 156
2020
Q4
$47K Buy
+144
New +$44.2K ﹤0.01% 524
2019
Q4
Sell
-136
Closed -$32K 484
2019
Q3
$32K Sell
136
-2,074
-94% -$568K ﹤0.01% 331
2019
Q2
$624K Buy
2,210
+619
+39% +$169K 0.07% 114
2019
Q1
$457K Buy
1,591
+1,125
+241% +$325K 0.06% 118
2018
Q4
$122K Buy
+466
New +$128K 0.04% 117
2017
Q3
Sell
-950
Closed -$179K 218
2017
Q2
$179K Sell
950
-235
-20% -$42.2K 0.08% 106
2017
Q1
$196K Buy
+1,185
New +$189K 0.11% 96

Other funds holding ELV

Pathstone Family Office's ELV Position: Q3 2023 in Review

Pathstone Family Office increased its Elevance Health (ELV) stake by 72% in Q3 2023, buying an estimated $4.22M and bringing the position to 22,208 shares worth $9.67M. The position accounts for 0.07% of the portfolio, ranked #176.

Pathstone Family Office first reported a position in ELV in Q1 2017 and has held it in 18 quarters since. The position peaked at $15.5M in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Pathstone Family Office held 22,208 shares of Elevance Health worth $9.67M as of Q3 2023.
  • Pathstone Family Office bought 9,305 Elevance Health shares in Q3 2023, an estimated $4.22M.
  • Elevance Health made up 0.07% of Pathstone Family Office's portfolio in Q3 2023, its #176 holding.
  • Pathstone Family Office first reported a position in Elevance Health in Q1 2017 and has held it in 18 quarters since.
  • Pathstone Family Office's Elevance Health position peaked at $15.5M in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.